Susan Broy MD FACP FACR CCD Professor of Clinical Medicine Rosalind Franklin School of Medicine, Chicago Medical School.

Slides:



Advertisements
Similar presentations
Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

Chapter 19 Chapter 19 The Mechanical Behavior of Bone Copyright © 2013 Elsevier Inc. All rights reserved.
How Should We Monitor, Prevent, and Treat Osteoporosis in IBD? All of Our IBD Patients are at Risk and Therefore all Should Begin Treatment at Diagnosis.
A progressive bone disease characterized by decrease bone mass decreased bone density increased fracture risk Dr Gaurav Rathore MS Ortho, MCh Ortho, FRCS.
Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.
Assoc. Prof. Chatlert Pongchaiyakul, MD. Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, KKU, THAILAND Role of ultrasound.
Chapter 66 Chapter 66 Clinical Use of Bone Densitometry Copyright © 2013 Elsevier Inc. All rights reserved.
Bone Quality PART 1 Introduction Architecture Turnover.
WHO Osteoporosis Definition (1996)
Bone Quality PART 3 Collagen/Mineral Matrix Conclusions Supplemental Slides.
Downloaded from 1 Alendronate vs. Risedronate Comparison Trial.
Bones Adaptation n Overuse: Exercise. Bone Adaptation n Disuse: bone mass is reduced.
OSC Recommendations for Bone Mineral Density Reporting Slides prepared by Kerry Siminoski, MD, FRCPC William Leslie, M.Sc., MD,
Osteoporosis UBC Internal Medicine Program Dr. Mark Fok Dr. Maria Ashley.
OSTEOPOROSIS and fracture risk Prof. J. Preželj KO za endokrinologijo, diabetes in presnovne bolezni.
Relationship of Drug Associated Change in Bone Mineral Density to Fracture Risk Marc C. Hochberg, MD, MPH FDA Endocrinologic and Metabolic Drugs Advisory.
Bone Mineral Density Testing March 29, Introduction Osteoporosis is a systemic skeletal disorder characterized by decreased bone mass and deterioration.
BONE DENSITOMETRY ( DEXA SCAN) Dr Malith Kumarasinghe MBBS (Colombo)
Chapter 9 Skeletal health. Chapter overview Introduction Biology of bone Osteoporosis: definition, prevalence and consequences Physical activity and bone.
Osteoporosis Rajesh Kataria, D.O.. Osteoporosis “…is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of.
ECTS symposium 5 Anabolic treatment of osteoporosis.
Selecting Candidates for Fracture Prevention Based on Risk Prediction Lubna Pal, MBBS, MRCOG, MS Assistant Professor Department of Obstetrics, Gynecology.
Interpretation of Bone mineral density
Multiparametric Imaging of Bone Architecture: a Cadaveric Study Aim The hypotheses tested include: 1) the presence of vertebral fractures will correlate.
1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium... 1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium...
Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women’s Health Initiative (WHI) Chlebowski RT et al. SABCS 2009; Abstract 21.
Copyright © 2013 Elsevier Inc. All rights reserved.
By Siraya Kitiyodom ปัญหาที่เกี่ยวกับสุขภาพ ที่พบบ่อยในสตรีวัยทอง และวิธีการดูแล (Part II)
June 2004 Bone Quality June 2004 A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue,
Falls Prevention 2007 The “Challenge” May 14, 2007 Dr. M. Sugai.
Internal Medicine Weekly Conference 1392 Internal Medicine Weekly Conference 1392 Alimohammad Fatemi Assistant Professor of Rheumatology Alimohammad Fatemi.
June 2004 Bone Quality Sourced from NIH Consensus Development Panel on Osteoporosis. JAMA 285: ; 2001 Architecture Turnover Rate Damage Accumulation.
Extended Treatment Effects with Zoledronic Acid Based on Poster 1070 “The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment in Osteoporosis: a Randomized.
UNIVERSITY of DERBY Implementing TA 161 and 204 in the real world Dr. Jonathan Bayly Visiting Fellow, University of Derby.
Estrogen plus Progestin, BMD and Fractures: Women’s Health Initiative Jane A. Cauley University of Pittsburgh JAMA 2003; 290 (13) :
AFF: Bone Density and Structure with BP Use Based on Poster FR0030 “Bone Density and Structure of Patients on Bisphosphonates with Atypical Femur Fractures”
Osteoporosis Armed Forces Academy of Medical Sciences.
Osteoporosis: Measuring the Problem
Alimohammad Fatemi Assistant Professor of Rheumatology 1.
TAMARA VOKES 1, DISHA KUMAR 1, MAUREEN COSTELLO 1 AND DIDIER HANS 2 UNIVERSITY OF CHICAGO MEDICINE, CHICAGO, ILLINOIS, USA 1 CENTER OF BONE DISEASES, LAUSANNE.
June 2004 Conclusion Slides. June 2004 Bone quality is an integral component of bone strength Maintaining or restoring bone architecture is required for.
REFERENCES 1. Leppänen, O., H. Sievänen, and T. Järvinen. “Biomechanical testing in experimental bone interventions – May the power be with you.” Journal.
ReferencePopulationInterventionSite MeasuredMeasurement Technique Children and Adolescents Macdonald et al. [19]EX: N= 281, CON: N=129 Age: 10.2 (0.6),
Prevention and Treatment of Osteoporosis
Osteoporosis In Thalassemia Dr Tarek Jawad INT 555.
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Understanding Bone Densitometry
Chapter 41: Role of Sex Steroids in the Pathogenesis of Osteoporosis Matthew T. Drake and Sundeep Khosla.
Chapter 47 Assessing Fracture Risk: Who Should Be Screened? © American Society for Bone and Mineral Research Contributed by John Schousboe, Brent Taylor,
Osteopenia and Osteoporosis Bradley K. Harrison, MD.
NICE, FRAX & NOGG VTS meeting Jonathan Day 7 th April 2010.
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
Date of download: 6/22/2016 Copyright © ASME. All rights reserved. From: The Importance of Intrinsic Damage Properties to Bone Fragility: A Finite Element.
Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.
Predicting Osteoporotic Hip Fractures: In Vitro Study of 80 Femurs Using Three Imaging Methods and Finite Element Modeling -- The European Fracture Study.
AND BENDING STRENGTH IN YOUNG ADULTS
Mouse Femoral Neck Architecture Determined by MicroCT Reflects
OSTEOPOROSIS Florence TREMOLLIERES, MD, PhD
Copyright © 2011 American Medical Association. All rights reserved.
THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.
Osteoporosis Diagnosis 9/21/2018 OSTEOPOROSIS.
dr. Muh. Ardi Munir, M.Kes, Sp.OT, M.H, FICS
Effects of the Assessment of 4 Determinants of Structural Geometry on QCT- and DXA- Derived Hip Structural Analysis Measurements in Elderly Women  Benjamin.
بنـام خـدا.
The Roles of Bone Mineral Density, Bone Turnover, and Other Properties in Reducing Fracture Risk During Antiresorptive Therapy  Solomon Epstein, MD  Mayo.
RAC-OST-POL Study population based Polish epidemiological study on postmenopausal osteoporosis prof. dr hab. n. med. Wojciech Pluskiewicz Medical University.
Protein for Healthy Bones
Reporting the Results of DXA Scan
Interpretation The World Health Organization (WHO) Osteoporosis Guidelines (T Score vs Z score) A Z-score less than –2 indicates the diagnosis is below.
Figure 1. Relative risks of vertebral, hip, and nonvertebral fractures (and 95% CIs) in response to the treatments for ... Figure 1. Relative risks of.
Presentation transcript:

Susan Broy MD FACP FACR CCD Professor of Clinical Medicine Rosalind Franklin School of Medicine, Chicago Medical School

No disclosures to report

 Introduction – what is bone strength?  Bone density  Bone quality  Measuring bone “quality”  Invasive  Imaging ▪ CT and MRI, including finite element analysis (FEA) ▪ DXA ▪ Hip structural analysis (HSA) ▪ Trabecular bone score (TBS)

4 Healthy bone “A skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture.” “Bone strength is a composite of bone density and bone quality” NIH Consensus Development Panel JAMA 2001;285:785

 Bone “quality”  Matrix properties ▪ Damage accumulation ▪ Collagen quality ▪ Mineralization (eg. crystal size)  Macroarchitecture ▪ Bone size ▪ Bone shape  Microarchitecture  Bone density  Explains 60-80% of bone strength in cadaveric studies 1,2 1 Cheng XG et al. J Bone Miner Res 1997;12: Bousson V et al. Osteoporos Int 2006;17:855-64

 Invasive  Mechanical studies of cadaveric bone = direct measurement of bone strength  Bone biopsy – tetracycline labeled ▪ Bone metabolism and structure Important in research but not clinically useful

 Invasive  Imaging by CT/MRI  HR-pQCT, µMRI: microarchitecture  QCT: ▪ 3-D geometry ▪ Finite element analysis (FEA)  Imaging by DXA  HSA – hip structural analysis ▪ Measures size and shape of femur i.e. macroarchitecture  TBS – trabecular bone score ▪ Evaluates microarchitecture of vertebrae Research Dr Engelke

Cylinder B has less bone but the same strength as cylinder A A larger bone (e.g. in a man) is a stronger bone than a smaller bone with the same volumetric density 1 1 Bruno AG et al. J Bone Miner Res 2014;29(3):

Source: NHANES III courtesy Dr. Anne Looker, National Center for Health Statistics, CDC Images courtesy of Tom Beck CSA does not decrease as much as BMD because of an increase in femoral neck width

Age Density Section modulus Inner and Outer Bone Diameters expand with age Slide courtesy of Dr Thomas Beck

Bending AxialCompression Uniform across bone surface, proportional to cross-surface area (CSA) Non-uniform across bone surface. Maximal at outer surfaces. Quantified by section modulus (SM) Axial Compression Bending

Males Females Aging leads to decreased BMD but periosteal expansion helps preserve section modulus, especially in males Beck TJ et al, J Bone Miner Res 2000;15:2297

 CSA: cross-sectional area  CSMI: cross-sectional moment of inertia  SM: section modulus  BR: buckling ratio  OD: outer diameter  HAL: hip axis length  NSA: neck-shaft angle Software programs HSA™ (Hologic) AHA™ (GE)

Line of pixels defines a cut plane through the bone Mass projected in cut plane describes bone cross-section Outer diameter CSA CSMI, Sm BR = Sm/length Profile and Cross-section have equal: OD

Mineral profiles are extracted from DXA images by software and used to estimate geometric properties. BMD, outer diameter, CSA and CSMI measured from profiles Sm and BR calculated Requires assumptions about bone shape and distribution of cortical and trabecular bone at each site. Image courtesy of Thomas J. Beck, ScD..

OD: Subperiosteal width CSA: cross-sectional area CSMI: cross-sectional moment of inertia Z = section modulus CT: cortical thickness BR: buckling ratio HAL : Hip axis length greater trochanter to inner pelvic rim NSA: neck-shaft angle (NSA)

Neck-shaft angle Outer diameter d1, d2: measurements of femoral neck length d3 = outer diameter y: measurement of radius at minimum CSMI alpha: angle femoral shaft to vertical theta: neck-shaft angle Yoshikawa T et al J Bone Miner Res 1994; 9: Faulkner KG et al Osteoporos Int 2006;17:593-9 Strength index (SI) = estimated strength/ expected stress

 Multiple studies have shown that hip geometry parameters are associated with risk of hip fracture  Hip geometry parameters (especially Sm, BR, HAL and NSA) are associated with hip fracture in postmenopausal women 1,2  NSA is associated with hip fracture in men and women 3  Measurements change with condition or treatment  Aging 4  Exercise 5  Pharmacologic therapy: estrogen, raloxifene, alendronate, denosumab, teriparatide 1 Kaptoge S et al. J Bone Miner Res 2008;23: Beck TJ et al J Bone Miner Res 2000;15;:297 2 Leslie WD et al. Osteoporos Int 2009;20: Hind K et al. Bone 2007;40: Faulkner KG et al. Osteoporos Int 2006;17:593

19 Buckling Ratio BMDCSACortical Thickness Section Modulus Mean Change From Baseline, % ALNRIS ALNRIS ALNRISALNRISALNRIS *P<0.05. † P< ALN = alendronate. RIS = risedronate. CSA = cross-sectional area. † * † † † † † † † † † † † † † † † † † † † † † † † † † Reproduced from Bonnick SI et al. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 16, 2006; Philadelphia, PA. Poster SA345. Alendronate 70 mg once weekly for 2 years Risedronate 35 mg once weekly for 2 years – – – –

 Pros  FDA-approved software ▪ HSA™ ▪ AHA ™  Can do at same time as DXA  Evidence correlates with fracture risk in women  Cons  Variable precision – depends on image quality, positioning  Except for HAL, not clear if fracture risk is independent of BMD  Need universally accepted standards for use ▪ Need cut-off points ▪ Can geometric measurements be incorporated into FRAX calculations? ISCD Position Development Conference addressing these issues

 Bone “quality”  Matrix properties ▪ Damage accumulation ▪ Collagen quality ▪ Mineralization (eg. crystal size)  Macroarchitecture ▪ Bone size ▪ Bone shape  Microarchitecture  Bone density  Explains 60-80% of bone strength in cadaveric studies* *Cheng XG et al. J Bone Miner Res 1997;12: Bousson V et al. Osteoporos Int 2006;17:855-64

NormalLoss ofLoss of Quantity andQuantityArchitecture Architecture Loss BMDNo change in BMD

Normal Dempster 2000 Microarchitectural Changes in Osteoporosis Osteoporotic Horizontal Disconnections

 Bone biopsy  HR-pQCT  Micro-MRI  TBS Research

 Textural index: DXA software that extracts bone texture information from a regular AP spine DXA scan image  Gray-level variations in the image provide an indirect assessment of microarchitecture  Has been shown to be related to bone microarchitecture and fracture risk  Provides information independent of BMD

Well-structured trabecular bone Degraded trabecular bone Pothuaud et al. Bone 2008;42: Hans et al. JCD 2011;14: Winzenrieth et al. JCD 2013; 16: Experimental variogram of pixel gray-levels DXA image

TBS = TBS = BMD=0.972 BMD=0.969 Silva BC at al. J Bone Miner Res 2014;29(3): Low variability, high amplitude Large variability, small amplitude

Normative database for USA: Simonelli C et al. J Clin Densitom 2014

 Many studies  61 entries for TBS in PubMed (November 2014)  1 ASBMR abstract in 2011, 19 in 2012, 33 in 2013, 22 in 2014  Correlates with mechanical behavior of cadaveric vertebrae 1  Correlates with microarchitectural parameters  Cadaveric vertebrae 1,2  In vivo µCT 3  Predicts fracture 3 1 Roux JP et al. Osteoporos Int 2013;24(9): Hans D et al. J Clin Densitom 2011;14(3): Silva BC at al. J Bone Miner Res 2014;29(3):518-30

Pothaud ‘09 Winzenreith ‘10 Rabier ‘10 Krueger’13 Lamy’12 Del Rio ‘13 Pothaud ‘09 Krueger ‘13 Lamy ‘12 Cross-sectional studiesProspective studies* Manitoba ’11 JPOS ‘13 OPUS ’13 Manitoba ‘11 OFELY ’13 OPUS Silva BC at al. J Bone Miner Res 2014;29(3): * F/U 4.7 – 8years

Hans D et al. J Bone Miner Res 2011;26: Manitoba, Canada N=29,407 women >50 Mean F/U 4.7 years 1668 major osteoporotic fractures (MOF)* *MOF = spine, hip, humerus or radius

ControlDiabetic with fracture Link TM Skeletal Radiol 2010;39: HR-pQCT Distal Tibia Postmenopausal Women

Leslie WD et al. J Clin Endocrinol Metab 2013;98:602-9 Odds ratios (95% CI bars) for BMD or TBS measurement in the lowest vs highest tertile according to presence of diabetes. TBS predicted fracture in those with diabetes as well as those without diabetes.

 Pros  FDA-approved in 2012  Can do at same time as DXA  EvidenceTBS correlates with ▪ Mechanical strength ▪ Microarchitectural parameters ▪ Fracture risk (cross-sectional and prospective studies )  Provides information independent of BMD  Might be helpful in cases of secondary osteoporosis ▪ Type 2 diabetes 1  Cons  No reimbursement  Need universally accepted standards for use ▪ Need cut-off points ▪ Can TBS be incorporated into FRAX calculations? 2 ▪ German osteoplogy society (DVO) 2014 guidelines include a TBS offset for FRAX calculations 1 Leslie WD et al. J Clin Endocrinol Metab 2013;98: Johannson H et al. IOF meeting 2013 Hong Kong ISCD PDC addressing these issues

 Bone strength includes bone density and bone “quality”  Bone “quality” can be assessed by  Invasive: mechanical studies of cadaveric bone, bone biopsy  Research: HR-pQCT, µMRI (microarchitecture), 3-D QCT (macroarchitecture)  Possible clinical use: ▪ FEA ▪ HSA (geometry i.e. macroarchitexture) ▪ TBS (microarchitecture) ISCD Position Development Conference Will review the evidence and develop official positions on the clinical utility of non DXA BMD measures of fracture risk